Rare
lephants
Screener
Toggle theme
Xenon Pharmaceuticals Inc.
XENE
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2014
FY2012
Total Cash from Operations:
$48.6M
Line Item
Value
% of Total
Capital Expenditures
$266.0K
0.5%
Working Capital
$14.3M
29.3%
Net Cash Flow
$34.1M
70.1%
Download CSV
